SPOTLIGHT -
Dr. Hays on the Importance of Clinical Trials in CRC
John L. Hays, MD, PhD, discusses the importance of clinical trials in colorectal cancer.
Read More
Dr. Hays on Treatment Options in HER2-Positive CRC
John L. Hays, MD, PhD, discusses expanding treatment options for HER2-positive colorectal cancer.
Dr. Hays on the Importance of Genetic Testing in Colorectal Cancer
John L. Hays, MD, PhD, discusses the importance of genetic testing in colorectal cancer.
Dr Berkenstock on ADC-Related Ocular Toxicities in Cervical and Ovarian Cancers
Dr Matalonis on the Management of Mirvetuximab Soravtansine-Related Toxicities in FRα+ Ovarian Cancer
Updated EMPOWER-Lung 3 Data Support Frontline Cemiplimab Plus Chemo in Advanced NSCLC
Neoadjuvant Nivolumab Plus Chemotherapy Retains EFS Advantage in Resectable NSCLC
